A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis

Leukemia Research ◽

10.1016/j.leukres.2014.11.018 ◽

2015 ◽

Vol 39 (2) ◽

pp. 157-163 ◽

Author(s):

Srdan Verstovsek ◽

Ronald Hoffman ◽

John Mascarenhas ◽

Jean-Charles Soria ◽

Ratislav Bahleda ◽

...

Keyword(s):

Phase I ◽

Jak2 Inhibitor ◽

Multi Center Study ◽

Download Full-text

Hydromorphone Hydrochloride Injection for Management of Cancer Pain: An Open-Label, Multi-Center Study for Japanese Cancer Patients

10.26226/morressier.5c76c8bae2ea5a72376124c2 ◽

2019 ◽

Author(s):

Hiroshi Takahashi

Keyword(s):

Cancer Pain ◽

Cancer Patients ◽

Multi Center Study ◽

Download Full-text

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2021.1902701 ◽

2021 ◽

pp. 1-10

Author(s):

Franco M. Piazza ◽

Miia Virta ◽

Marita Paassilta ◽

Benita Ukkonen ◽

Anitta Ahonen ◽

...

Keyword(s):

Conjugate Vaccine ◽

Meningococcal Disease ◽

Booster Dose ◽

Phase Iii ◽

Multi Center Study ◽

Quadrivalent Meningococcal Conjugate Vaccine ◽

Download Full-text

Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging

Journal of Nuclear Cardiology ◽

10.1007/s12350-021-02527-8 ◽

2021 ◽

Author(s):

Jamieson M. Bourque ◽

Christopher A. Hanson ◽

Denis Agostini ◽

Timothy M. Bateman ◽

Jeroen J. Bax ◽

...

Keyword(s):

Coronary Artery Disease ◽

Suspected Coronary Artery Disease ◽

Emission Tomography ◽

Second Phase ◽

Phase 3 ◽

Positron Emission ◽

Artery Disease ◽

Multi Center Study ◽

Download Full-text

A RANDOMIZED, OPEN-LABEL, COMPARATIVE, MULTI-CENTER STUDY TO ASSES THE SAFETY AND EFFICACY OF PROGRAF/MYFORTIC AND ADVAGRAF/MYFORTIC IN DE NOVO LIVER TRANSPLANT RECIPIENTS— A PRELIMINARY REPORT

Transplantation Journal ◽

10.1097/00007890-201007272-01225 ◽

2010 ◽

Vol 90 ◽

pp. 642

Author(s):

T. Chen ◽

H. Yang ◽

C. Hsieh ◽

S. Cheng ◽

Y. Lin ◽

...

Keyword(s):

Liver Transplant ◽

Preliminary Report ◽

De Novo ◽

Transplant Recipients ◽

Safety And Efficacy ◽

Multi Center Study ◽

Liver Transplant Recipients ◽

Download Full-text

Corrigendum to “ An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression – A prospective, open-label, multi-center study” [Trav. Med. Infect. Dis. 21, January–February 2018, 43–50]

Travel Medicine and Infectious Disease ◽

10.1016/j.tmaid.2018.09.008 ◽

2019 ◽

Vol 27 ◽

pp. 115

Author(s):

Anja Rosdahl ◽

Christian Herzog ◽

Gert Frösner ◽

Torbjörn Norén ◽

Lars Rombo ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Hepatitis A ◽

Adult Patients ◽

Priming Dose ◽

Drug Induced ◽

Multi Center Study ◽

Download Full-text

Tocilizumab Improves Arterial Stiffness As Well As Other Biologics with Methotrexate-Resistant Active Rheumatoid Arthritis-An Open Label, Randomized Cohort Multi Center Study

OMICS Journal of Radiology ◽

10.4172/2167-7964.1000186 ◽

2015 ◽

Vol 04 (03) ◽

Author(s):

Kensuke Kume

Keyword(s):

Rheumatoid Arthritis ◽

Arterial Stiffness ◽

Active Rheumatoid Arthritis ◽

Multi Center Study ◽

Download Full-text

Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study

Vascular Health and Risk Management ◽

10.2147/vhrm.s4151 ◽

2008 ◽

Vol Volume 4 ◽

pp. 1407-1416 ◽

Author(s):

Toivo Laks ◽

Keba ◽

Leiner ◽

Euro Merilind ◽

Mall Petersen ◽

...

Keyword(s):

Clinical Practice ◽

High Risk ◽

High Risk Patients ◽

Parallel Group ◽

Risk Patients ◽

Multi Center Study ◽

Center Study ◽

Real Clinical Practice

Download Full-text

Abstract CT206: PFK-158, first-in-man and first-in-class inhibitor of PFKFB3/ glycolysis: A phase I, dose escalation, multi-center study in patients with advanced solid malignancies

10.1158/1538-7445.am2015-ct206 ◽

2015 ◽

Author(s):

Rebecca Redman ◽

Paula Pohlmann ◽

Michael Kurman ◽

Gilles H. Tapolsky ◽

Jason Chesney

Keyword(s):

Phase I ◽

Dose Escalation ◽

Solid Malignancies ◽

Multi Center Study ◽

Download Full-text

S220. BLONANSERIN AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA – WHO IS BENEFITED FROM BLONANSERIN AUGMENTATION? AN OPEN-LABEL, PROSPECTIVE, MULTI-CENTER STUDY

Schizophrenia Bulletin ◽

10.1093/schbul/sby018.1007 ◽

2018 ◽

Vol 44 (suppl_1) ◽

pp. S411-S411

Author(s):

Won-Myong Bahk ◽

Young Joon Kwon ◽

Bo-Hyun Yoon ◽

Sang-Yeol Lee ◽

Kwanghun Lee ◽

...

Keyword(s):

Multi Center Study ◽

Download Full-text

Correction to: A phase 2, open-label, multi-center study to evaluate the efficacy and safety of 99mTc-TRODAT-1 SPECT to detect Parkinson’s disease

Annals of Nuclear Medicine ◽

10.1007/s12149-019-01434-w ◽

2020 ◽

Vol 34 (1) ◽

pp. 38-38

Author(s):

Yu Sun ◽

Congjin Liu ◽

Zhengping Chen ◽

Biao Li ◽

Zhongwei Lv ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Phase 2 ◽

Efficacy And Safety ◽

Multi Center Study ◽

Download Full-text